VC-backed Surface Oncology appoints chief scientific officer
Cambridge, Massachusetts-based Surface Oncology Inc, a developer of next-generation cancer immunotherapies, has named Dr. Vito J. Palombella as chief scientific officer. Previously, Palombella worked at Infinity Pharmaceuticals where he served as executive vice president and chief scientific officer. Surface's backers include Atlas Venture, Lilly Ventures and New Enterprise Associates.
28 January 2016•3 mins read
